pharma
#pharma
pharma
Nvidia-Backed Biotech Says AI Could Make Biology Programmable
pharma
Generative AI Is Reshaping the Hunt for New Drugs
pharma
AI Is Rewriting Drug Discovery — But Its Biggest Bottleneck Isn't the Algorithm
pharma
RFK Jr. Opens the Door to Softer U.S. Vaccine Recommendations
pharma
QuantHealth Banks $45M to Simulate Clinical Trials Before They Happen
pharma
Healthcare AI Has the Technology. Does It Still Have Public Permission?
pharma
Experts Say AI Could Move Medicine From Diagnosing Illness to Predicting It
pharma
AI Can Now Guess What to Test Next — and Pharma Is Betting on It
pharma
Senate Picks Up BINSA, the Bill Aimed at Choking Off US-China Biotech Deals
pharma
Dash Bio Lands $30M Series A for a Pitch Investors Didn't Want to Hear
pharma
India's Traditional Medicine Ministry Steps Into Its AI Moment
pharma
Insilico Medicine Wants to Grade the AI Models Trying to Invent Drugs
pharma
Dario Health Rolls Out an Integrated GLP-1 Management Platform
pharma
AstraZeneca's AI Has Yet to Produce a Single Drug Candidate — But Its CEO Sees Another Use
pharma
OpenAI Is Linking 300 Million Weekly Health Questions to Real Medical Records
pharma
AI Drug Discovery Draws Investor Buzz as Market Forecasts Reach Billions
pharma
UK Biotech Funding Roars Back to a Record in Q2 2026
pharma
Bristol Myers and Nvidia to Build Pharma's Most Powerful AI Supercomputer
pharma
Study Says AI Can Predict a Patient's Risk of Death
pharma
Quantum Sampling Charts a New Path Through the Vast World of Peptides
pharma
Utah Becomes First State to Put AI to Work on Prescriptions
pharma
GSK Scraps $2 Billion Cough Drug After Phase 3 Stumble
pharma
Jasper Finds a Lifeline in Merger With Immune Drugmaker Kira
pharma
AI Is Reshaping How Pharma Runs Clinical Trials
pharma
Kalshi Opens Betting on Drug Trial Outcomes and FDA Decisions
pharma
Chai Discovery Lands $400M, Tripling Its Value to $3.8 Billion
pharma
Biopharma's Deal Frenzy Sets the Stage as Earnings Season Opens
pharma
Pharma's AI Bet Grows Up: Big Forecasts, a First Phase III, and Hard Questions
pharma
Anthropic Sets Its Sights on Drug Discovery — But Experts Say the Hard Part Comes Later
pharma
FDA Reverses Course, Posts 14 Pharma Rejection Letters Online
pharma
Pharma Bets Big on AI, From $1.4B Heart-Drug Push to Indian Analytics Overhaul
pharma
Meet Biomni: The AI That Runs Biomedical Research From Search to Experiment
pharma
US Government Bets $160M on One-of-a-Kind Gene Editing Cures
pharma
AI, Synthetic Biology and Robotics Team Up to Build Better Enzymes
pharma
AI Cracks How Drugs Latch Onto Proteins
pharma
Anthropic's CEO Weighs In on What AI Could Mean for Biotech
pharma
Anthropic Wants to Make Its Own Drugs, Not Just Sell AI to Labs
pharma
Anthropic Steps Into Drug Discovery, Targeting Neglected Diseases
pharma
Takeda Bets on AI, Signs Drug Discovery Deal With Insilico Worth Up to $600 Million
pharma
Biotech Megarounds Rebound as 40 Startups Land $100M+ in Early 2026
ai
Anthropic Bets on Science With New Claude Research Workbench
pharma
Anthropic Bets Big on Drug Discovery With New 'Claude Science' Platform
pharma
AI Moves From Buzzword to Deal-Maker in Drug Discovery
pharma
Metsera's Founders Bet on an 'AI Scientist' to Spin Up New Biotechs
pharma
Machine Learning Aims to Rewrite Life's Genetic Code for Biotech
pharma
Biotech's Top Lobbyist Pitches a Single Playbook for AI, Rules and National Security
pharma
Biogen Pauses Most of Apellis Pipeline Just Months After $5.6B Buyout
pharma
Life Science Labs Are Still in the Testing Phase With AI
pharma
AWS Shows How to Build a Protein Research Copilot on Bedrock
pharma
SandboxAQ and NVIDIA Team Up on AI Tool to Speed Drug Discovery
pharma
Biotech IPO Window Cracks Open — But Only for a Chosen Few
pharma
Insilico Inks AI Drug Discovery Pact Worth Up to $2.5 Billion
pharma
HHS Launches Sweeping Push to Speed Up Clinical Trials
pharma
ICON Bets on Microsoft Copilot to Speed Up Clinical Trials
pharma
Bayer Turns to Iambic's AI Platform in New Drug Discovery Push
pharma
Sanofi Taps Paulo Fontoura to Lead R&D as Ashrafian Exits
pharma
Takeda Joins the AI Drug Hunt, Teaming Up With Iambic
pharma
Researchers Turn AI Loose on Hard-to-Treat Gonorrhea
pharma
AI Dons the Lab Coat as Research Labs Embrace Automation
pharma
India Eyes the Biotech Ground America Is Leaving Behind
pharma
Biotech Leaders Navigate AI Drug Discovery Amid Funding and Regulatory Shifts
pharma
Boltz Signs AI Drug Discovery Deal With Pharma Giant Takeda
pharma
Eli Lilly's TuneLab AI Program Crosses 100 Members, Adds Chai's Models
pharma
Innoviva Resurrects Lyndra's Long-Acting Oral Drug Platform
pharma
Washington Post Spotlights China's Growing Biotech Dominance in the AI Era
pharma
NIH Says New AI Tool Could Speed Up Antibiotic Development
pharma
OpenAI's Near-Autonomous AI Chemist Improves a Key Drug-Making Reaction
pharma
Lilly Snaps Up Non-Opioid Pain Startup in Latest Dealmaking Push
pharma
AI Drug Discovery's Real Bottleneck? It's the Biology Data, Not the AI
pharma
Lilly's $2.3B Bet on Blood Cancer Drug Pays Off Early
pharma
Pharma's Billion-Dollar AI Bet Is Reshaping Drug Discovery
pharma
AI Drug Discovery Is Booming — But Hurdles Remain
pharma
AI Could Fix Drug Trials — If Humans Stay in the Driver's Seat
pharma
AI and Cell Painting Are Quietly Rewriting How New Drugs Get Made
pharma
Eli Lilly Bets Up to $2.75 Billion on AI-Designed Drugs in Insilico Medicine Deal
pharma
Novo Nordisk Bets on OpenAI to Reshape Drug Discovery and the Factory Floor
pharma